Epoch 3: Slow Week in Biotech - Post-JPM Hangover
Interest Cuts, Taiwan Election, Pharma Realignment, Private Valuations
Welcome to the 72 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1,585 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.